63
Participants
Start Date
July 31, 2010
Primary Completion Date
August 31, 2013
Study Completion Date
April 30, 2015
Cvac
Cvac consists of autologous dendritic cells (DCs) incubated with the antigen, mannosylated fusion protein (M-FP), to target the DCs to the specific mucin 1 antigen.
Peter MacCallum Cancer Cetnre, East Melbourne
Austin Health Cancer Centre, Heidelberg
Greenslopes Private Hospital, Greenslopes
Gold Coast Hospital, Southport
Royal Adelaide Hospital, Adelaide
New York Downtown Hospital, New York
Duke University Medical Center, Durham
Medical University of South Carolina, Charleston
Northside Hospital, Atlanta
Collaborative Research Group, Boca Raton
Cleveland Clinic Foundation, Cleveland
Indiana University Simon Cancer Center, Indianapolis
Scripps Cancer Center, La Jolla
University of California, San Francisco, San Francisco
Stanford University School of Medicine, Palo Alto
Marin Cancer Care, Inc., Greenbrae
University of Washington Medical Center, Seattle
Morristown Medical Center, Morristown
Lead Sponsor
Prima BioMed Ltd
INDUSTRY